FDA Raps Ascend Therapeutics for Misleading Estrogel Claims By Sam | August 29, 2018 The FDA on Tuesday issued Ascend Therapeutics an untitled letter over misleading claims for its estrogen therapy Estrogel. Source: Drug Industry Daily Posted in Drug Industry Daily